BillionToOne (BLLN) Return on Assets (2025 - 2026)

BillionToOne (BLLN) posted Return on Assets of 0.0% for Q1 2026, up 589.41% sequentially from 0.0% in Q4 2025.

BillionToOne (BLLN) Return on Assets (2025 - 2026) Analysis & Trends

BillionToOne has reported Return on Assets for 2 years, with the latest figure at 0.0% in Q1 2026.

  • Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY) and the FY2025 annual result came in at 0.0%, changed N/A from the prior year.
  • Return on Assets rose to 0.0% in Q1 2026 per BLLN's latest filing, from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2026 and troughed at 0.0% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Thermo Fisher Scientific 213.88 Bn 209.81 Bn 8.34 Bn 0.00%
2 Danaher 140.65 Bn 136.30 Bn 3.61 Bn 0.00%
3 Idexx Laboratories 46.02 Bn 45.83 Bn 779.09 Mn 0.00%
4 Agilent Technologies 39.85 Bn 38.05 Bn 990.00 Mn 0.00%
5 Iqvia Holdings 39.20 Bn 37.12 Bn 1.44 Bn 0.00%
6 Natera 38.80 Bn 37.70 Bn 696.04 Mn 0.00%
7 Illumina 30.11 Bn 28.94 Bn 770.00 Mn 0.00%
8 Mettler Toledo International 28.66 Bn 28.61 Bn 650.22 Mn 0.00%
9 Quest Diagnostics 26.24 Bn 25.61 Bn 1.03 Bn 0.00%
10 BillionToOne 6.88 Bn 6.34 Bn 79.10 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%